Long-Term Outcomes of Patients with Liver Cirrhosis After Eradication of Chronic Hepatitis C with Direct-Acting Antiviral Drugs (DAAs)
Despite achieving SVR, continuous surveillance for HCC and new-onset decompensation is mandatory in patients with liver cirrhosis.
Authors
- Eman Abdelsameea (ORCID: https://orcid.org/0000-0002-3225-7164)
- Maha Elsabaawy (ORCID: https://orcid.org/0000-0002-3110-1547)
- Nehad Darwesh
- Asmaa Gomaa (ORCID: https://orcid.org/0000-0001-9376-4461)
- Mohsen Salama (ORCID: https://orcid.org/0000-0002-1637-407X)
- Aliaa Sabry (ORCID: https://orcid.org/0000-0002-1674-2573)
Institutions
- Menoufia University (EG)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/jhc.s475810
- Citations
- 2
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.74